November 16, 2025 — Leads & Copy — GE HealthCare’s CFO, Jay Saccaro, will speak at the upcoming Jefferies Global Healthcare Conference in London, England on Tuesday, November 18, 2025, at 9:30 am GMT/4:30 am ET/3:30 am CT. A webcast of the event will be available on the GE HealthCare website.
Saccaro is expected to discuss the company’s business strategy and growth opportunities. He will also comment on a competitor’s FDA approval of an X-Ray contrast product, clarifying that GE HealthCare does not anticipate a significant impact on its Pharmaceutical Diagnostics business.
GE HealthCare Technologies Inc. is a global healthcare solutions provider that innovates medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. The company aims to improve the efficiency of hospitals and health systems, enhance clinician effectiveness, refine therapies, and promote patient well-being.
With a history spanning over 125 years, GE HealthCare focuses on personalized, connected, and compassionate care while simplifying the patient’s journey across care pathways. Its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses are dedicated to enhancing patient care throughout the spectrum, from screening and diagnosis to therapy and monitoring.
GE HealthCare has a $19.7 billion business with approximately 53,000 employees. GE HealthCare is recognized as one of the 2025 Fortune World’s Most Admired Companies™.
Follow GE HealthCare on LinkedIn, X, Facebook, Instagram, and Insights for updates.
Source: GE HealthCare Technologies Inc.
